Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals Inc. Stock

20.49P/E
€87.06BMarket capitalisation
US$45.24Earnings
0.38 %Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approvedfor wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Regeneron Pharmaceuticals Inc. is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Regeneron Pharmaceuticals Inc. stock.

Market capitalisation
€87.06B
P/E
20.49
P/B
2.85
P/S
5.85
P/CF
20.32
Issued shares 102M Units

Return

Here you can see the performance of the Regeneron Pharmaceuticals Inc. stock.

PeriodPerfor­mance
1 Week-1.68 %
1 Month+20.56 %
3 Months+17.41 %
6 Months+59.98 %
1 Year+37.01 %
YTD+27.15 %

Dividends

The Regeneron Pharmaceuticals Inc. stock pays an annual dividend. With an (expected) annual dividend of £3.3625, the current stock price results in a dividend yield of 0.38 %.

Dividend typeAnnual dividend
(Expected) annual dividend £3.3625
Dividend yield 0.38 %

Splits

The table shows the splits of the Regeneron Pharmaceuticals Inc. share.

DateRatio
No data available.

Which ETF contains the Regeneron Pharmaceuticals Inc. stock?

The Regeneron Pharmaceuticals Inc. stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Regeneron Pharmaceuticals Inc. has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Regeneron Pharmaceuticals Inc. stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.